Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone
    Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone
    • News

  • Aerometrex Expands MetroMap Partner Program as Scalable Model Gains Traction
    Aerometrex Expands MetroMap Partner Program as Scalable Model Gains Traction
    • News

  • Middle East Conflict Starts to Hurt Corporate Earnings Outlooks
    Middle East Conflict Starts to Hurt Corporate Earnings Outlooks
    • News

  • European Lithium and Critical Metals Secure Control of Tanbreez Rare Earth Project
    European Lithium and Critical Metals Secure Control of Tanbreez Rare Earth Project
    • News

  • Harris Technology’s refurbished boom signals FY26 profit inflection
    Harris Technology’s refurbished boom signals FY26 profit inflection
    • News

Vection Secures $7.3M Defence Extension as AI Demand Strengthens

  • In News
  • July 29, 2025
  • Tim Grey
Vection Secures $7.3M Defence Extension as AI Demand Strengthens

AI Gains Ground in Defence Sector

As governments increase investment in defence technology, AI-powered tools are carving out a central role in modern military infrastructure. Vection Technologies (ASX:VR1) has secured a $7.3 million extension to an existing defence contract, confirming its foothold in a multi-year digital transformation program for a European client.

“This follow-up award reflects both operational excellence and continued customer trust in our technologies,” said Vection Managing Director Gianmarco Biagi.

Contract Extension Builds on $10M in Past Deliveries

The latest order follows a $4.4 million defence contract announced on 30 June 2025 and takes Vection’s cumulative work with this client to over $10 million. The contract involves delivery of Vection’s AI products, which are part of its INTEGRATEDXR® platform, and will be delivered using existing resources—without any additional cost to the company.

“We look forward to continuing to work as a key defence partner,” said Biagi.

Client Commits with No Termination Rights

Notably, the contract has been issued with no termination rights for the client. It’s part of a broader annual delivery plan that includes another $19 million budgeted for this vertical between FY27 and FY29.

The structure of the deal is designed to support future extensions, with similar orders expected over the next four years subject to performance.

Vection expects to recognise $5.4 million of this award as revenue in FY26, and a further $1.9 million in Q1 FY27.

“This contract supports our expansion success in this key vertical for Vection,” Biagi added.

Incumbent Position Strengthened

The company’s role as the incumbent partner is reinforced by this repeat order, signalling trust from its defence client as it rolls out a long-term digital transformation strategy. The delivery of Vection’s AI solutions forms a core component of that initiative, highlighting the relevance of its technology in a defence context.

More to Come Under Approved $19M Budget

The defence client’s broader budget of $19 million for the same vertical between FY27 and FY29 positions Vection to potentially capture additional high-value orders. These would likely follow the same structure and delivery model, assuming performance metrics are met.

This announcement is deemed material by the company, as it exceeds Vection’s materiality threshold of $500,000 in revenue.

With this $7.3 million defence extension, Vection Technologies has reaffirmed its growing role in the defence sector’s shift toward AI and digital solutions. The company remains well positioned to capture future value from a locked-in $19 million budget and a long-term strategic relationship.

 

  • About
  • Latest Posts
Tim Grey
Latest posts by Tim Grey (see all)
  • AML3D announces stronger FY26, with positive EBITDA reported in the second half - September 1, 2026
  • Imagion Biosystems Advances MagSense® Phase 2 Trial - August 27, 2026
  • Acrux-developed Menopause Hormone Therapy to enter Australian market - May 28, 2026
  •  
  •  
  •  
  •  
  • VR1
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Tim Grey
Latest posts by Tim Grey (see all)
  • AML3D announces stronger FY26, with positive EBITDA reported in the second half - September 1, 2026
  • Imagion Biosystems Advances MagSense® Phase 2 Trial - August 27, 2026
  • Acrux-developed Menopause Hormone Therapy to enter Australian market - May 28, 2026

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Tim Grey
Latest posts by Tim Grey (see all)
  • AML3D announces stronger FY26, with positive EBITDA reported in the second half - September 1, 2026
  • Imagion Biosystems Advances MagSense® Phase 2 Trial - August 27, 2026
  • Acrux-developed Menopause Hormone Therapy to enter Australian market - May 28, 2026
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.